Search results
The main objection to the medical use of marijuana by the federal government is largely attributable today to a national policy of zero-tolerance toward illicit drugs.
An ethical objection to recommendation of medical marijuana use but not attestation of a qualifying condition may hinge on what the physician perceives to be their degree of involvement, and thus, moral culpability, in a patient's immoral action.
This template covers various aspects, such as compliance with state laws, drug testing protocols, accommodations for medical marijuana use, and disciplinary actions for policy violations. Customizing this template to align with your business operations and local legislation ensures that your Marijuana Policy is relevant, effective, and enforceable.
The principles of biomedical ethics--beneficence and nonmaleficence, respect for autonomy, and justice--can help to guide cannabis care. To uphold the principles of beneficence and nonmaleficence, providers should recommend cannabis only for conditions where the evidence base is well-established.
A medical cannabis policy would allow for legal, physician-certified medical marijuana usage by employees. For most companies, this means that employees would need to disclose whether they were currently using, or planned to use, medical marijuana as part of a treatment plan.
Introduction. The key to being a successful medical cannabis advocate is effective communication. Specifically, advocates must be able to: 1) convey the most important arguments in support of medical cannabis laws, and 2) respond to arguments made in opposition to medical cannabis laws.
Controversy in the United States about the decriminalization of cannabis to allow health care providers to recommend it for therapeutic use (medical marijuana) has been based on varying policies and beliefs about cannabis rather than on scientific evidence.
